Clinical Trial Update: Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Lecozotan SR in mild to moderate Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lecozotan SR (lecozotan SR)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED